Cliff Asness's TEVA Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 44,195 shares of Teva Pharmaceutical Industries Limited (TEVA) worth $892,738, representing 0.00% of the portfolio. First purchased in 2014-Q2, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in TEVA, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2014, adding 103,108 shares. Largest reduction occurred in Q1 2015, reducing 206,919 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Teva Pharmaceutical Industries Limited (TEVA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Teva Pharmaceutical Industries Limited (TEVA) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2014 | +103,811 | New Buy | 103,811 | $52.42 |
| Q3 2014 | +103,108 | Add 99.32% | 206,919 | $53.75 |
| Q1 2015 | -206,919 | Sold Out | 0 | $0.00 |
| Q2 2024 | +16,144 | New Buy | 16,144 | $16.25 |
| Q3 2024 | +1,433 | Add 8.88% | 17,577 | $18.02 |
| Q4 2024 | +1,646 | Add 9.36% | 19,223 | $22.04 |
| Q1 2025 | +4,732 | Add 24.62% | 23,955 | $15.37 |
| Q2 2025 | +2,074 | Add 8.66% | 26,029 | $16.76 |
| Q3 2025 | +18,166 | Add 69.79% | 44,195 | $20.20 |
Cliff Asness's Teva Pharmaceutical Industries Limited Investment FAQs
Cliff Asness first purchased Teva Pharmaceutical Industries Limited (TEVA) in Q2 2014, acquiring 103,811 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Teva Pharmaceutical Industries Limited (TEVA) for 10 quarters since Q2 2014.
Cliff Asness's largest addition to Teva Pharmaceutical Industries Limited (TEVA) was in Q2 2014, adding 103,811 shares worth $5.44 M.
According to the latest 13F filing for Q3 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 44,195 shares of Teva Pharmaceutical Industries Limited (TEVA), valued at approximately $892,738.
As of the Q3 2025 filing, Teva Pharmaceutical Industries Limited (TEVA) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Teva Pharmaceutical Industries Limited (TEVA) was 206,919 shares, as reported at the end of Q3 2014.